| Date Filed | Type | Description |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/19/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/28/2023 |
8-K
| Quarterly results |
| 04/14/2023 |
8-K
| Quarterly results |
| 03/27/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/21/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/20/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 03/07/2023 |
8-K
| Results of Operations and Financial Condition Interactive Data |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 10% stake in Synaptogenix, Inc. |
| 01/18/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/09/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 12/28/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 12/28/2022 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ... |
| 12/28/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 12/16/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 12/16/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 11/22/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 11/22/2022 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits ... |
| 11/18/2022 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E... |
| 08/25/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 08/25/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 08/16/2022 |
8-K
| Quarterly results |
| 08/05/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 05/13/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 04/28/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 04/15/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 03/29/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2022 |
SC 13G/A
| HAYWOOD GEORGE WEAVER reports a 7% stake in Synaptogenix, Inc. |
| 01/31/2022 |
SC 13G/A
| ALPHA CAPITAL ANSTALT reports a 4.5% stake in SYNAPTOGENIX, INC. |
| 11/12/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 10/01/2021 |
8-K
| Quarterly results |
| 08/13/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
|